Regarding renal carcinomas, further studies revealed that it is particularly strong in clear cell RCC: histopathological evaluations of 109 primary tumors showed PSMA expression in 76.2% of clear cell RCC, 31.2% of chromophobe RCC, but none in papillary RCC [3]. Here, FOLH1 is linked to renal carcinoma.